DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Chang KC, Tseng PL, Wu YY. , et al.
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.

Clin Gastroenterol Hepatol 2015;
13 (05) 1017-1024

Download Bibliographical Data

Access:
Access:
Access: